Skip to content

Myosin5B, a Prognostic and Predictive Marker for CRC Patients

Gene signature for the prediction of recurrence and response to chemotherapy in early stage colorectal cancer patient

Published: 25th March 2020
Myosin5B, a Prognostic and Predictive Marker for CRC Patients
LCpl Austin Schlosser-Flickr-CC0 https://www.flickr.com/photos/39955793@N07/10928038965
Patents
  • WO 2019/034549 Novel Biomarkers For Cancer Diagnosis, Prediction Or Staging
IP Status
  • Patent application submitted
Seeking
  • Licensing
  • Commercial partner
  • Development partner